News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Lettmann Jason
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2020 |
4
| Lettmann Jason (10% Owner) has filed a Form 4 on ALX ONCOLOGY HOLDINGS INC|
Txns:
| Converted 88,704 shares
@ $0
Converted 1,831,027 shares
@ $0
Converted 249,632 shares
@ $0
Bought 378,000 shares
@ $19, valued at
$7.2M
Converted 1,498,984 shares
@ $0
Bought 22,000 shares
@ $19, valued at
$418k
Converted 111,528 shares
@ $0
Converted 78,175 convertible preferred
@ $0
Converted 1,633,743 convertible preferred
@ $0
Converted 222,752 convertible preferred
@ $0
Converted 683,523 convertible preferred
@ $0 |
|
| 07/17/2020 |
4
| Lettmann Jason (10% Owner) has filed a Form 4 on ALX ONCOLOGY HOLDINGS INC|
Txns:
| Granted 24,009 options to buy
@ $19, valued at
$456.2k
|
|
| 06/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/31/2016 |
4
| Lettmann Jason (Director) has filed a Form 4 on Ra Pharmaceuticals, Inc.|
Txns:
| Exercised (in-or-at-the-money) 63,019 shares
@ $0.07, valued at
$4.4k
Sold 340 shares
@ $13, valued at
$4.4k
Converted 1,392,130 shares
@ $0
Converted 523,438 shares
@ $0
Converted 486,919 shares
@ $0
Converted 542,702 shares
@ $0
Converted 73,945 shares
@ $0
Converted 504,839 shares
@ $0
Converted 68,786 shares
@ $0
Bought 263,538 shares
@ $13, valued at
$3.4M
Bought 114,752 shares
@ $13, valued at
$1.5M
|
|
|
|